These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 28575299)

  • 1. Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study.
    Quigley CA; Child CJ; Zimmermann AG; Rosenfeld RG; Robison LL; Blum WF
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3195-3205. PubMed ID: 28575299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
    Child CJ; Zimmermann AG; Chrousos GP; Cummings E; Deal CL; Hasegawa T; Jia N; Lawrence S; Linglart A; Loche S; Maghnie M; Pérez Sánchez J; Polak M; Predieri B; Richter-Unruh A; Rosenfeld RG; Yeste D; Yorifuji T; Blum WF
    J Clin Endocrinol Metab; 2019 Feb; 104(2):379-389. PubMed ID: 30219920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M; González Navarrete D; Tolosa Navarro F; López Cuevas P; Rodríguez Convertino F; Román Reyes R
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study.
    Carel JC; Ecosse E; Landier F; Meguellati-Hakkas D; Kaguelidou F; Rey G; Coste J
    J Clin Endocrinol Metab; 2012 Feb; 97(2):416-25. PubMed ID: 22238382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
    Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics.
    Albertsson-Wikland K; Mårtensson A; Sävendahl L; Niklasson A; Bang P; Dahlgren J; Gustafsson J; Kriström B; Norgren S; Pehrsson NG; Odén A
    J Clin Endocrinol Metab; 2016 May; 101(5):2149-59. PubMed ID: 26918292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of growth hormone treatment in pediatric patients with idiopathic short stature.
    Quigley CA; Gill AM; Crowe BJ; Robling K; Chipman JJ; Rose SR; Ross JL; Cassorla FG; Wolka AM; Wit JM; Rekers-Mombarg LT; Cutler GB
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5188-96. PubMed ID: 15899952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.
    Bakker B; Frane J; Anhalt H; Lippe B; Rosenfeld RG
    J Clin Endocrinol Metab; 2008 Feb; 93(2):352-7. PubMed ID: 18000092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Diabetes Treated in Early Adulthood After Growth Hormone Treatment of Short Stature in Childhood.
    Poidvin A; Weill A; Ecosse E; Coste J; Carel JC
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1291-1298. PubMed ID: 28324032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and humanistic aspects of growth hormone deficiency and growth-related disorders.
    Rogol AD
    Am J Manag Care; 2011 Dec; 17 Suppl 18():eS4-10. PubMed ID: 22590765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P; Bjerknes R; Dahlgren J; Dunkel L; Gustafsson J; Juul A; Kriström B; Tapanainen P; Aberg V
    Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.